Jackie Walling
Vice President, Clinical Development
Dr. Jackie Walling joined BioMarin in June 2009 and serves as Vice President of Clinical Development with responsibility for Clinical Science, Clinical Operations, Pharmacovigilance and Biometrics. Dr. Walling has previously served in various positions at Axys (VP of Clinical Development), Tularik (Medical Director) and Eli Lilly and Company (Director of Science and Operations). At Eli Lilly and Company Dr. Walling made a significant contribution to the development and registration of both gemcitabine and pemetrexed. Dr. Walling received her MBChB from Bristol University, UK, and her Ph.D. from Southampton University, UK.